Literature DB >> 10383141

Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells.

S Y Sun1, P Yue, G S Wu, W S El-Deiry, B Shroot, W K Hong, R Lotan.   

Abstract

CD437 is a novel retinoid that can induce apoptosis in a variety of tumor cell types by an unknown mechanism. We found that CD437 up-regulated the expression of p21(WAF1/CIP1), Bax, and Killer/DR5 and induced G1 arrest and rapid apoptosis in three human non-small cell lung carcinoma cell lines with wild-type p53 but not in five cell lines with mutant p53, suggesting a role for p53 in the effects of CD437. Using H460 cells in which wild-type p53 protein was degraded by transfection of the human papillomavirus 16 E6 (HPV-16 E6) gene and H460 cells transfected with a control plasmid only, we found that CD437 increased p53, p21(WAF1/CIP1), Bax, and Killer/DR5 in the control transfectants. In contrast, the constitutive p53 protein level was suppressed, and the ability of CD437 to increase p53 and its downstream genes was compromised in E6 transfectants. In addition, CD437 induced G1 arrest and apoptosis in the control transfectants but not in the E6-transfected cells. These results indicate that p53 plays a role in CD437-induced growth inhibition and apoptosis in human non-small cell lung carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383141

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Highly twisted adamantyl arotinoids: synthesis, antiproliferative effects and RXR transactivation profiles.

Authors:  Santiago Pérez-Rodríguez; Maria A Ortiz; Raquel Pereira; Fátima Rodríguez-Barrios; Angel R de Lera; F Javier Piedrafita
Journal:  Eur J Med Chem       Date:  2009-01-20       Impact factor: 6.514

2.  Astroglial U87 Cells Protect Neuronal SH-SY5Y Cells from Indirect Effect of Radiation by Reducing DNA Damage and Inhibiting Fas Mediated Apoptotic Pathway in Coculture System.

Authors:  Yasmeen Saeed; Abdul Rehman; Bingjie Xie; Jin Xu; Ma Hong; Qing Hong; Yulin Deng
Journal:  Neurochem Res       Date:  2015-07-05       Impact factor: 3.996

Review 3.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

4.  Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance.

Authors:  Anju Singh; Manish Bodas; Nobunao Wakabayashi; Fred Bunz; Shyam Biswal
Journal:  Antioxid Redox Signal       Date:  2010-07-13       Impact factor: 8.401

5.  Synergistic and additive effect of retinoic acid in circumventing resistance to p53 restoration.

Authors:  Connie A Larsson; Sydney M Moyer; Bin Liu; Keith A Michel; Vinod Pant; Peirong Yang; Justin Wong; Adel K El-Naggar; Ralf Krahe; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-13       Impact factor: 11.205

6.  Escherichia coli induces apoptosis in human monocytic U937 cells through the Fas/FasL signaling pathway.

Authors:  Jia-He Wang; Yang Peng; Li-Li Yang; Yi-Bing Wang; Bao-Gang Wu; Yi Zhang; Ping He
Journal:  Mol Cell Biochem       Date:  2011-06-21       Impact factor: 3.396

7.  Simultaneous targeting of ATM and Mcl-1 increases cisplatin sensitivity of cisplatin-resistant non-small cell lung cancer.

Authors:  Fuquan Zhang; Mingjing Shen; Li Yang; Xiaodong Yang; Ying Tsai; Peter C Keng; Yongbing Chen; Soo Ok Lee; Yuhchyau Chen
Journal:  Cancer Biol Ther       Date:  2017-07-07       Impact factor: 4.742

8.  IGFBP-3 mediates p53-induced apoptosis during serum starvation.

Authors:  Adda Grimberg; Bingrong Liu; Peter Bannerman; Wafik S El-Deiry; Pinchas Cohen
Journal:  Int J Oncol       Date:  2002-08       Impact factor: 5.650

9.  In silico discovery of novel retinoic acid receptor agonist structures.

Authors:  M Schapira; B M Raaka; H H Samuels; R Abagyan
Journal:  BMC Struct Biol       Date:  2001-06-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.